tiprankstipranks
Advertisement
Advertisement

Stryker maintains FY26 adjusted EPS outlook of $14.90-$15.10, consensus $14.96

Maintains FY26 guidance of organic net sales growth in the range of 8.0%-9.5%. The sales guidance includes a modestly positive pricing impact. Additionally, foreign exchange is expected to have a slightly favorable impact on both sales and adjusted net earnings per diluted share should rates hold near current levels.

Meet Samuel – Your Personal Investing Prophet

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1